Anixa Biosciences Inc SEC filings ANIX

Anixa Biosciences Inc has 983 filings in SEC EDGAR's recent list, going back to Jun 9, 1995. Its latest annual report, Form 10-K, was filed on Jan 12, 2026 for the period ended Oct 31, 2025. The latest quarterly report (Form 10-Q) was filed on Sep 9, 2026, covering the quarter ended Jul 31, 2026. The most recent current report (Form 8-K) was filed on Mar 11, 2026 (shareholder vote results, regulation fd disclosure). The company's fiscal year ends on October 31.

Form Description Filed Period
10-K Annual report Jan 12, 2026 Oct 31, 2025
10-K Annual report Jan 10, 2025 Oct 31, 2024
10-K Annual report Jan 16, 2024 Oct 31, 2023
10-K Annual report Jan 4, 2023 Oct 31, 2022
10-K Annual report Jan 4, 2022 Oct 31, 2021
10-K Annual report Jan 7, 2021 Oct 31, 2020
10-K/A Amended annual report Jan 10, 2020 Oct 31, 2019
10-K Annual report Jan 9, 2020 Oct 31, 2019
10-K Annual report Jan 11, 2019 Oct 31, 2018
10-K Annual report Jan 9, 2018 Oct 31, 2017
10-K/A Amended annual report Dec 8, 2016 Oct 31, 2016
10-K Annual report Dec 7, 2016 Oct 31, 2016
10-K Annual report Dec 23, 2015 Oct 31, 2015
10-K/A Amended annual report Jan 29, 2015 Oct 31, 2014
10-K Annual report Jan 29, 2015 Oct 31, 2014
10-K/A Amended annual report Apr 16, 2014 Oct 31, 2013
10-K/A Amended annual report Jan 17, 2014 Oct 31, 2013
10-K Annual report Jan 16, 2014 Oct 31, 2013
ARS Annual report to shareholders Aug 27, 2013 Oct 31, 2012
10-K Annual report Jan 29, 2013 Oct 31, 2012
10-K Annual report Jan 30, 2012 Oct 31, 2011
10-K Annual report Feb 14, 2011 Oct 31, 2010
10-K/A Amended annual report Jun 29, 2010 Oct 31, 2009
10-K/A Amended annual report Mar 10, 2010 Oct 31, 2009
10-K Annual report Jan 29, 2010 Oct 31, 2009
10-K Annual report Jan 16, 2009 Oct 31, 2008
10-K Annual report Jan 15, 2008 Oct 31, 2007
10-K/A Amended annual report Jan 25, 2007 Oct 31, 2006
10-K Annual report Jan 16, 2007 Oct 31, 2006
10-K Annual report Jan 31, 2006 Oct 31, 2005
10-K/A Amended annual report Apr 22, 2005 Oct 31, 2004
10-K/A Amended annual report Jan 18, 2005 Jan 18, 2005
10-K Annual report Jan 18, 2005 Oct 31, 2004
10-K Annual report Dec 22, 2003 Oct 31, 2003
10-K Annual report Feb 13, 2003 Oct 31, 2002
10-K Annual report Jan 29, 2002 Oct 31, 2001
10-K/A Amended annual report Feb 1, 2001 Oct 31, 2000
10-K Annual report Jan 29, 2001 Oct 31, 2000
10-K Annual report Jan 28, 2000 Oct 31, 1999
10-K/A Amended annual report Mar 31, 1999 Oct 31, 1998

Showing 40 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ANIX (Nasdaq)
Fiscal year ends
October 31
Incorporated in
DE
Headquarters
San Jose, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
715446
Former names
ITUS Corp (until Sep 27, 2018); COPYTELE INC (until Aug 27, 2014)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.